Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
J Clin Apher ; 22(5): 258-64, 2007.
Article in English | MEDLINE | ID: mdl-17823946

ABSTRACT

The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.


Subject(s)
Blood Banks/standards , Practice Guidelines as Topic/standards , Product Labeling/standards , Transplants/standards , Blood Transfusion/standards , Guideline Adherence , Humans , International Cooperation , Quality Control , Software
5.
Stem Cells ; 25(8): 2087-93, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17510215

ABSTRACT

Umbilical cord blood (UCB) is an important source of hematopoietic stem cells for transplantation. Although UCB is often collected from unrelated donors, directed umbilical cord blood (DCB) from sibling donors also provides an important source of UCB for transplantation. This report summarizes the experience in collection, testing, storage, and transplantation of DCB units by the National Blood Service for England and North Wales over 10 years. Eligibility for collection was based on an existing sibling suffering from a disease that may be treated by stem cell transplantation or a family history that could result in the birth of a sibling with a disease that could be treated by stem cell transplantation. Collections were made on the provision that the sibling's clinician was willing to financially support the collection and to take responsibility for medical review of the mother and potential recipient. Given the high investment in UCB banking and the introduction of new regulations and mandatory licensing under the European Union Tissues and Cells Directive and those proposed in the U.S., this report details the procedures that we have used for DCB donations, the outcome data where donations have been used for transplantation, and it provides some timely recommendations for best practices. Disclosure of potential conflicts of interest is found at the end of this article.


Subject(s)
Blood Donors , Cord Blood Stem Cell Transplantation/methods , Directed Tissue Donation , Fetal Blood/cytology , Siblings , Blood Banking/methods , Child , Child, Preschool , England , Female , Fetal Blood/microbiology , Follow-Up Studies , Hematologic Diseases/epidemiology , Hematologic Diseases/therapy , Humans , Retrospective Studies , Transplantation/mortality , Transplantation, Homologous , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...